OBJECTIVES: The aim of this study was to investigate the metabolomic profile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty balloon-induced transient coronary occlusion. BACKGROUND: Biochemical detection of MIS is a major challenge. The validation of novel biosignatures is of utmost importance. METHODS: High-resolution nuclear magnetic resonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after controlled ischemia) from swine (n = 9) and patients (n = 20) undergoing transitory MIS in the setting of planned coronary angioplasty. Additionally, blood serum of control patients (n = 10) was sequentially profiled. Preliminary clinical validation of the developed metabolomic biosignature was undertaken in patients with spontaneous acute chest pain (n = 30). RESULTS: Striking differences were detected in the blood profiles of swine and patients immediately after MIS. MIS induced early increases (10 min) of circulating glucose, lactate, glutamine, glycine, glycerol, phenylalanine, tyrosine, and phosphoethanolamine; decreases in choline-containing compounds and triacylglycerols; and a change in the pattern of total, esterified, and nonesterified fatty acids. Creatine increased 2 h after ischemia. Using multivariate analyses, a biosignature was developed that accurately detected patients with MIS both in the setting of angioplasty-related MIS (area under the curve 0.94) and in patients with acute chest pain (negative predictive value 95%). CONCLUSIONS: This study reports, to the authors' knowledge, the first metabolic biosignature of acute MIS developed under highly controlled coronary flow restriction. Metabolic profiling of blood plasma appears to be a promising approach for the early detection of MIS in patients.
OBJECTIVES: The aim of this study was to investigate the metabolomic profile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty balloon-induced transient coronary occlusion. BACKGROUND: Biochemical detection of MIS is a major challenge. The validation of novel biosignatures is of utmost importance. METHODS: High-resolution nuclear magnetic resonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after controlled ischemia) from swine (n = 9) and patients (n = 20) undergoing transitory MIS in the setting of planned coronary angioplasty. Additionally, blood serum of control patients (n = 10) was sequentially profiled. Preliminary clinical validation of the developed metabolomic biosignature was undertaken in patients with spontaneous acute chest pain (n = 30). RESULTS: Striking differences were detected in the blood profiles of swine and patients immediately after MIS. MIS induced early increases (10 min) of circulating glucose, lactate, glutamine, glycine, glycerol, phenylalanine, tyrosine, and phosphoethanolamine; decreases in choline-containing compounds and triacylglycerols; and a change in the pattern of total, esterified, and nonesterified fatty acids. Creatine increased 2 h after ischemia. Using multivariate analyses, a biosignature was developed that accurately detected patients with MIS both in the setting of angioplasty-related MIS (area under the curve 0.94) and in patients with acute chest pain (negative predictive value 95%). CONCLUSIONS: This study reports, to the authors' knowledge, the first metabolic biosignature of acute MIS developed under highly controlled coronary flow restriction. Metabolic profiling of blood plasma appears to be a promising approach for the early detection of MIS in patients.
Authors: Vicente Bodi; Vannina G Marrachelli; Oliver Husser; Francisco J Chorro; Juan R Viña; Daniel Monleon Journal: J Cardiovasc Transl Res Date: 2013-08-29 Impact factor: 4.132
Authors: Arantxa Hervas; Amparo Ruiz-Sauri; Elena de Dios; Maria Jose Forteza; Gema Minana; Julio Nunez; Cristina Gomez; Clara Bonanad; Nerea Perez-Sole; Jose Gavara; Francisco Javier Chorro; Vicente Bodi Journal: J Anat Date: 2015-10-29 Impact factor: 2.610
Authors: Lin Piao; Yong-Hu Fang; Kishan Parikh; John J Ryan; Peter T Toth; Stephen L Archer Journal: J Mol Med (Berl) Date: 2013-06-21 Impact factor: 4.599
Authors: Folarin Erogbogbo; Jasmine May; Mark Swihart; Paras N Prasad; Katie Smart; Seif El Jack; Dariusz Korcyk; Mark Webster; Ralph Stewart; Irene Zeng; Mia Jullig; Katherine Bakeev; Michelle Jamieson; Nikolas Kasabov; Banu Gopalan; Linda Liang; Raphael Hu; Stefan Schliebs; Silas Villas-Boas; Patrick Gladding Journal: Theranostics Date: 2013-09-04 Impact factor: 11.556
Authors: Patrick A Gladding; Andrew Cave; Mehran Zareian; Kevin Smith; Jagir Hussan; Peter Hunter; Folarin Erogbogbo; Zoraida Aguilar; David S Martin; Eugene Chan; Margie L Homer; Abhijit V Shevade; Mohammad Kassemi; James D Thomas; Todd T Schlegel Journal: J Pers Med Date: 2013-08-21
Authors: Carmen Galbis-Estrada; Sebastián Martinez-Castillo; José M Morales; Bárbara Vivar-Llopis; Daniel Monleón; Manuel Díaz-Llopis; María Dolores Pinazo-Durán Journal: Biomed Res Int Date: 2014-05-21 Impact factor: 3.411
Authors: Aslan T Turer; Gregory D Lewis; John F O'Sullivan; Sammy Elmariah; Jessica L Mega; Tayo A Addo; Marc S Sabatine; James A de Lemos; Robert E Gerszten Journal: PLoS One Date: 2014-06-16 Impact factor: 3.240
Authors: Vannina G Marrachelli; Daniel Monleon; Pilar Rentero; María L Mansego; Jose Manuel Morales; Inma Galan; Remedios Segura; Fernando Martinez; Juan Carlos Martin-Escudero; Laisa Briongos; Pablo Marin; Gloria Lliso; Felipe Javier Chaves; Josep Redon Journal: PLoS One Date: 2014-06-11 Impact factor: 3.240